Top Page
De.mem Ltd.
(Sydney:DEM)
De.mem Ltd. (DEM) vs. iShares MSCI Australia ETF (EWA)
De.mem Ltd. Business Overview & Revenue Model
De.mem Ltd. Financial Statement Overview
| Breakdown | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 24.90M | 23.41M | 19.64M | 18.08M | 14.16M |
| Gross Profit | 10.16M | 8.39M | -521.00K | -1.54M | 3.68M |
| EBITDA | -1.01M | -1.23M | -1.70M | -2.93M | -2.75M |
| Net Income | -2.77M | -3.13M | -3.49M | -4.47M | -3.54M |
Balance Sheet | |||||
| Total Assets | 20.58M | 18.70M | 20.56M | 22.05M | 11.22M |
| Cash, Cash Equivalents and Short-Term Investments | 3.72M | 2.47M | 5.39M | 8.82M | 5.08M |
| Total Debt | 1.37M | 1.65M | 1.40M | 1.64M | 562.44K |
| Total Liabilities | 7.66M | 7.13M | 6.25M | 7.67M | 4.51M |
| Stockholders Equity | 12.92M | 11.57M | 14.31M | 14.35M | 6.71M |
Cash Flow | |||||
| Free Cash Flow | -10.00K | -2.23M | -3.65M | -3.73M | -2.00M |
| Operating Cash Flow | 115.00K | -1.45M | -1.88M | -2.31M | -1.16M |
| Investing Cash Flow | -1.22M | -728.00K | -3.97M | -4.31M | -1.35M |
| Financing Cash Flow | 2.28M | -485.00K | 2.32M | 10.54M | -544.06K |
De.mem Ltd. Technical Analysis
De.mem Ltd. Peers Comparison
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
71 Outperform | AU$39.30M | 8.78 | 20.77% | 4.17% | 66.80% | 625.00% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
57 Neutral | AU$184.61M | 19.29 | 7.04% | 2.78% | 4.52% | -31.16% | |
49 Neutral | AU$30.81M | ― | -16.00% | ― | 11.53% | 46.15% | |
48 Neutral | AU$88.12M | ― | ― | ― | 11.44% | 19.49% | |
46 Neutral | AU$21.81M | ― | -25.77% | ― | 4.84% | -12.12% | |
44 Neutral | AU$5.00M | ― | -26.47% | ― | -45.80% | -210.00% |
De.mem Ltd. Corporate Events
De.mem Limited, a company listed on the Australian Securities Exchange (ASX:DEM), has announced the acquisition of Core Chemicals. This acquisition is expected to enhance De.mem’s market position by integrating Core Chemicals’ national business portfolio and leveraging synergies between the two companies. The transaction is anticipated to strengthen De.mem’s financial outlook and capitalize on opportunities within the surging gold sector.
De.mem Ltd. has announced a proposed issue of 3,471,429 ordinary fully paid securities, with the issue date set for October 24, 2025. This move is part of a placement or other type of issue, and the company has submitted the necessary information to the ASX for the potential quotation of these securities. The announcement signifies a strategic financial maneuver to potentially enhance the company’s capital structure, which could impact its market position and stakeholder interests.
De.mem Ltd. has announced a proposed issue of 2,380,952 ordinary fully paid securities, scheduled for January 16, 2026. This move is part of a placement or other type of issue, which could potentially enhance the company’s capital base and support its growth initiatives in the water treatment sector.
De.mem Ltd. has announced a proposed issue of 26,190,477 ordinary fully paid securities, scheduled for issuance on October 24, 2025. This move is part of a placement or other type of issue, and the company has applied for these securities to be quoted on the ASX. The announcement indicates a strategic step for De.mem Ltd., potentially impacting its market operations and providing opportunities for stakeholders.
De.mem Ltd has acquired Core Chemicals Pty Ltd, a specialty chemicals supplier to the gold mining sector in Western Australia, for approximately $3 million. This strategic acquisition is expected to enhance De.mem’s market presence in the surging gold mining sector, offering significant revenue synergies and growth opportunities. The acquisition will allow De.mem to expand its client base and product offerings, leveraging the strong bull market in gold prices. The combined operations are projected to yield a pro-forma EBITDA of $1.6 million, with additional cost savings anticipated through operational integration.
De.mem Limited has requested a trading halt on its securities pending an announcement related to an acquisition transaction and capital raising. This move is aimed at managing its continuous disclosure obligations, with the halt expected to last until the announcement is made or normal trading resumes on October 20, 2025. The outcome of this announcement could significantly impact De.mem’s operations and market positioning.
De.mem Ltd. announced the cessation of 500,000 securities due to the expiry of options without exercise or conversion, effective October 3, 2025. This development may impact the company’s capital structure, but specific implications for stakeholders or the company’s market positioning were not detailed in the announcement.
De.mem Ltd. has announced record first-half results for 2025, highlighting strong financial performance and high operating leverage. The company’s successful acquisition track record and positive outlook underscore its strong industry positioning, promising significant implications for stakeholders.
De.mem Limited has announced its 2025 half-year financial results, showcasing significant growth and financial improvements. The company reported a record half-year revenue of $14 million, a 20% increase from the previous year, and a first positive half-year adjusted EBITDA of $556,000. With 25 consecutive quarters of cash receipts growth and a strong balance sheet, De.mem is on track for record full-year results, highlighting its robust market positioning and operational efficiency.
De.mem Limited reported record financial results for the first half of 2025, with a 20% increase in revenue to $14.0 million and a 16% rise in cash receipts to $15.7 million. The company achieved its first positive adjusted EBITDA of $556,000, marking a significant milestone. With 25 consecutive quarters of cash receipts growth and a strategic focus on recurring revenue, De.mem is on track for a record full calendar year 2025, providing strong cash flow visibility and a robust growth outlook.
De.mem Limited reported a 19.7% increase in revenues to $13.964 million for the half-year ending June 30, 2025, with a significant reduction in net loss by 42.4% to $980,000. The company also improved its gross profit margins from 40% to 43%, reflecting a 26% increase in gross profit, while adjusted EBITDA turned positive, indicating improved operational efficiency.
De.mem Ltd. announced the cessation of 250,000 securities due to the lapse of conditional rights, as the conditions were not met or became incapable of being satisfied. This announcement may impact the company’s capital structure and could influence stakeholder perceptions of its financial health and strategic planning.
De.mem Ltd. announced the cessation of certain securities, specifically options that expired without exercise or conversion. The cessation involves 2,000,000 options expiring on August 2, 2025, and 500,000 options expiring on August 3, 2025. This announcement may impact the company’s capital structure and investor perceptions.
De.mem Limited reported record cash receipts for the June Quarter 2025, with approximately $7.8 million, marking the second highest in its history. The company achieved a 16% increase in cash receipts over the first half of 2025 compared to the previous year, significantly outperforming the industry average growth rate. De.mem maintained positive operating cash flows for the fourth consecutive quarter, generating $533,000, and continued to invest in its Singapore subsidiary for membrane technology development. The company’s strong financial performance and strategic investments position it well for continued growth and industry leadership.